Theriva Biologics, Inc. TOVX
0.16 USD 0.00 (-2.83%)
Nov 10, 2026, 11:22 AM EST
0.1564 Day range 0.1658
0.14 52-week range 0.49
- YTD
- -23.29%
- 1 year
- -44.45%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -24.05M | -26.35M | -21.43M | -21.58M | -14.27M | |
| -23.74M | -25.65M | -18.35M | -19.68M | -14.27M | |
| -2.08 | -19.03 | -28.48 | -32.80 | -47.50 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 13.10M | 11.71M | 23.28M | 41.88M | 67.33M | |
| 38.24M | 35.35M | 55.22M | 71.86M | 70.36M | |
| 22.86M | 16.29M | 15.52M | 17.30M | 4.96M | |
| 2.63M | 1.56M | 2.15M | 1.68M | 1.53M | |
| 15.38M | 19.07M | 36.96M | 51.83M | 65.41M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -16.67M | -16.94M | -19.00M | -19.08M | -12.89M | |
| -35.00K | -1.00K | -202.00K | -4.40M | -14.00K | |
| 18.19M | 5.50M | 625.00K | -1.93M | 74.00M | |
| -35.00K | -1.00K | -202.00K | -116.00K | -14.00K | |
| 1.40M | -11.57M | -18.61M | -25.41M | 61.10M |